Search research articles
Contact Us
Filters
Showing results (371-380 of 462) with videos related to
Page
of 47
Sort By:
Arthritis and Rheumatism
|
August 29, 2009
Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna, Ron D Hays, Paul Maranian, et al.
AIDS Research and Human Retroviruses
|
January 1, 1991
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
G J Clements, M J Price-Jones, P E Stephens, et al.
Veterinary Parasitology
|
August 15, 2000
Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients
R H Six, R G Clemence, C A Thomas, et al.
The American Journal of Cardiology
|
March 1, 1991
Frequency of late potentials in systemic sclerosis
D K Moser, W G Stevenson, M A Woo, et al.
Bioorganic & Medicinal Chemistry
|
February 11, 2011
Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity
John Spencer, Rajendra P Rathnam, Alan L Harvey, et al.
The American Journal of Medicine
|
June 1, 1988
Prognostic importance of cardiac arrhythmias in systemic sclerosis
J B Kostis, J R Seibold, D Turkevich, et al.
Frontiers in Physiology
|
August 11, 2018
One-Year Consumption of a Mediterranean-Like Dietary Pattern With Vitamin D3 Supplements Induced Small Scale but Extensive Changes of Immune Cell Phenotype, Co-receptor Expression and Innate Immune Responses in Healthy Elderly Subjects: Results From the United Kingdom Arm of the NU-AGE Trial
Monica Maijo, Kamal Ivory, Sarah J Clements, et al.
Rheumatology (Oxford, England)
|
October 5, 2010
Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials
Mahsa Nashid, Puja P Khanna, Daniel E Furst, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.
Arthritis Research & Therapy
|
December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials
Dinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.
Page
of 47
Search research articles
Search
Showing results (371-380 of 462) with videos related to
Sort By:
Page
of 47
Arthritis and Rheumatism
|
August 29, 2009
Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna, Ron D Hays, Paul Maranian, et al.
AIDS Research and Human Retroviruses
|
January 1, 1991
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
G J Clements, M J Price-Jones, P E Stephens, et al.
Veterinary Parasitology
|
August 15, 2000
Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients
R H Six, R G Clemence, C A Thomas, et al.
The American Journal of Cardiology
|
March 1, 1991
Frequency of late potentials in systemic sclerosis
D K Moser, W G Stevenson, M A Woo, et al.
Bioorganic & Medicinal Chemistry
|
February 11, 2011
Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity
John Spencer, Rajendra P Rathnam, Alan L Harvey, et al.
The American Journal of Medicine
|
June 1, 1988
Prognostic importance of cardiac arrhythmias in systemic sclerosis
J B Kostis, J R Seibold, D Turkevich, et al.
Frontiers in Physiology
|
August 11, 2018
One-Year Consumption of a Mediterranean-Like Dietary Pattern With Vitamin D3 Supplements Induced Small Scale but Extensive Changes of Immune Cell Phenotype, Co-receptor Expression and Innate Immune Responses in Healthy Elderly Subjects: Results From the United Kingdom Arm of the NU-AGE Trial
Monica Maijo, Kamal Ivory, Sarah J Clements, et al.
Rheumatology (Oxford, England)
|
October 5, 2010
Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials
Mahsa Nashid, Puja P Khanna, Daniel E Furst, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.
Arthritis Research & Therapy
|
December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials
Dinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.
Page
of 47